|
|
|
Insider
Information: |
Smolokowski Wiaczeslaw |
Relationship: |
10% Owner |
City: |
Switzerland |
State: |
G4 |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
9,848,632 |
|
Indirect Shares
|
10,258,079 |
|
|
Direct
Value |
$35,526,039 |
|
|
Indirect Value
|
$9,941,104 |
|
|
Total
Shares |
20,106,711 |
|
|
Total
Value |
$45,467,143 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
4
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
4
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-4.0
|
Percentage
Gain/Loss : |
-26.2%
|
-230.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Karyopharm Therapeutics Inc. |
KPTI |
10% Owner |
2019-02-28 |
6,000,000 |
2013-11-12 |
10,258,079 |
Premium* |
|
Acrivon Therapeutics, Inc. |
ACRV |
10% Owner |
2023-06-26 |
3,848,632 |
2022-11-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
68 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
KPTI |
Karyopharm Therapeutics I... |
10% Owner |
|
2018-08-10 |
4 |
S |
$18.50 |
$12,987 |
D/D |
(702) |
8,261,561 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
10% Owner |
|
2018-08-27 |
4 |
S |
$18.52 |
$259,776 |
D/D |
(14,026) |
8,247,535 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
10% Owner |
|
2018-08-29 |
4 |
S |
$19.59 |
$3,918,280 |
D/D |
(200,000) |
8,047,535 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
10% Owner |
|
2018-08-30 |
4 |
S |
$21.00 |
$4,199,900 |
D/D |
(200,000) |
7,847,535 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
10% Owner |
|
2018-08-31 |
4 |
S |
$21.05 |
$241,396 |
D/D |
(11,468) |
7,836,067 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
10% Owner |
|
2018-09-04 |
4 |
S |
$20.60 |
$824,072 |
D/D |
(40,000) |
7,796,067 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
10% Owner |
|
2018-09-05 |
4 |
S |
$21.06 |
$3,370,256 |
D/D |
(160,000) |
7,636,067 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
10% Owner |
|
2018-09-06 |
4 |
S |
$20.52 |
$98,474 |
D/D |
(4,800) |
7,631,267 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
10% Owner |
|
2019-02-25 |
4 |
S |
$4.99 |
$3,994,880 |
D/D |
(800,000) |
6,831,267 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
10% Owner |
|
2019-02-26 |
4 |
S |
$5.00 |
$617,210 |
D/D |
(123,400) |
6,707,867 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
10% Owner |
|
2019-02-27 |
4 |
S |
$4.51 |
$2,515,834 |
D/D |
(558,243) |
6,149,624 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
10% Owner |
|
2019-02-28 |
4 |
S |
$4.14 |
$619,114 |
D/D |
(149,624) |
6,000,000 |
0 |
- |
|
ACRV |
Acrivon Therapeutics, Inc... |
10% Owner |
|
2022-11-17 |
4 |
B |
$12.50 |
$5,000,000 |
D/D |
400,000 |
3,856,597 |
2.45 |
% |
|
ACRV |
Acrivon Therapeutics, Inc... |
10% Owner |
|
2022-11-17 |
4 |
A |
$0.00 |
$0 |
D/D |
3,456,597 |
3,856,597 |
0 |
- |
|
ACRV |
Acrivon Therapeutics, Inc... |
10% Owner |
|
2023-06-12 |
4 |
S |
$12.34 |
$24,680 |
D/D |
(2,000) |
3,854,597 |
0 |
% |
|
ACRV |
Acrivon Therapeutics, Inc... |
10% Owner |
|
2023-06-13 |
4 |
S |
$12.30 |
$36,900 |
D/D |
(3,000) |
3,851,597 |
0 |
% |
|
ACRV |
Acrivon Therapeutics, Inc... |
10% Owner |
|
2023-06-14 |
4 |
S |
$12.13 |
$10,832 |
D/D |
(893) |
3,850,704 |
0 |
% |
|
ACRV |
Acrivon Therapeutics, Inc... |
10% Owner |
|
2023-06-26 |
4 |
S |
$12.93 |
$207 |
D/D |
(16) |
3,848,632 |
0 |
% |
|
68 Records found
|
|
Page 3 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|